Musculoskeletal

Evaluation of NMES for Reducing Pain and Improving Functional Outcomes in Knee OA Patients

Conditions:   Knee Osteoarthritis;   Knee Pain Chronic;   Knee Arthritis
Intervention:   Device: Active NMES
Sponsor:   CyMedica Orthopedics, Inc
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 10, 2019Comments OffEvaluation | Functional | Improving | Knee | NMES | Outcomes | Pain | Patients | Reducing
Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Conditions:   Amyloid;   Amyloidosis;   Spinal Stenosis;   Transthyretin Amyloidosis;   Primary Amyloidosis of Light Chain Type
Intervention:   Procedure: Biopsy
Sponsor:   The Cleveland Clinic
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 9, 2019Comments OffAmyloidosis | Flavum | Ligamentum | Screening | Systemic
L-Citrulline Dose Finding Safety Study in MELAS

Condition:   MELAS Syndrome
Intervention:   Drug: L-Citrulline
Sponsors:   Baylor College of Medicine;   National Institutes of Health (NIH);   University of South Florida;   Columbia University
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 8, 2019Comments OffDose | Finding | LCitrulline | MELAS | Safety | Study
Randomized Controlled Trial of Blood Flow Restriction + Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis

Condition:   Lateral Epicondylitis
Interventions:   Device: Blood flow restriction tourniquet;   Other: Evidence based physical/occupational therapy
Sponsor:   Akron General Medical Center
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 7, 2019Comments OffAlone | Blood | Controlled | Epicondylitis | Flow | Lateral | Physical | RAndomized | Restriction | Therapy | Trial
Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis

Condition:   Myositis
Intervention:   Drug: Celecoxib
Sponsor:   National Institute of Mental Health (NIMH)
Recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 5, 2019Comments OffArthritis | Biomarkers | Inflammatory | Myositis | Novel | Radioligands | Rheumatoid
Gait Retraining Enhances Athletes’ Technique

Conditions:   Anterior Cruciate Ligament Injury;   Knee Osteoarthritis
Intervention:   Other: Therapeutic Intervention
Sponsors:   Keller Army Community Hospital;   Telemedicine & Advanced Technology Research Center
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019Comments OffAthletes | Enhances | Gait | Retraining | Technique
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Condition:   Arthritis, Rheumatoid
Interventions:   Biological: GSK3196165;   Drug: Tofacitinib;   Drug: Placebo to GSK3196165;   Drug: Placebo to Tofacitinib;   Drug: csDMARDs
Sponsors:   GlaxoSmithKline;   IQVIA
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffActive | Antirheumatic | Arthritis | Conventional | cs/Biologic | Disease | DMARDs | Drugs | Efficacy | GSK3196165 | Inadequate | Moderately | Modifying | Participants | Placebo | Response | Rheumatoid | Safety | Severely | Synthetic | Tofacitinib | Versus
Biologic Therapy to Prevent Osteoarthritis After ACL Injury

Condition:   Anterior Cruciate Ligament Injuries
Interventions:   Drug: Anakinra injection;   Procedure: sterile saline injection
Sponsors:   University of California, Los Angeles;   Orthopedic Research and Education Foundation
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 1, 2019Comments OffAfter | Biologic | Injury | Osteoarthritis | Prevent | Therapy